Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Roxithromycin Tablets in Healthy Subjects
NCT06798051Phase 1Completed
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jun 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of roxithromycin in pharyngitis, tonsillitis, sinusitis and 7 more (3 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Maximum Observed Serum or Plasma Concentration at 3 days, Area Under the Serum or Plasma Concentration-Time Curve from 0 to t at 3 days and 1 more. Started Jun 2019; status: completed.
02
Drugs
roxithromycin
03
Conditions
pharyngitistonsillitissinusitisotitis mediaacute bronchitis
Beyond the preview
Go deeper on NCT06798051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798051.